Perceptions of drug companies have changed during the COVID era, CP3 Director Dr. Walid Gellad talked to Vox about what it means. “I think now, you don’t have all those stories about insulin and Epipen, plus you have positive stories about vaccines and other drugs,” he said. “You don’t have as fertile an environment for more extreme drug measures.”